What is the Basic Drug List? What is the full name?

The list of basic drugs is the national list of essential drugs.

It is the basis for the allocation and use of drugs by medical institutions, including two parts: the allocation and use of primary medical and health institutions and the use of other medical institutions. The drugs in the list of essential medicines are drugs that meet the basic medical and health needs, are appropriate, reasonable, and can be guaranteed by the public, and will be implemented on September 21, 2009.

The Catalogue of Basic Drugs is the National Essential Medicines Catalogue

The National Essential Medicines List is the basis for the allocation and use of drugs by medical institutions, and includes two parts: the part allocated and used by primary medical and health institutions and the part allocated and used by other medical institutions. The drugs in the list of essential medicines are drugs that meet the basic medical and health needs, are appropriate, reasonable, and can be guaranteed by the public, and will be implemented on September 21, 2009.

The basic drug catalogue is the basis for the allocation and use of drugs by medical institutions, and includes two parts: the allocation and use of primary medical and health institutions and the allocation and use of other medical institutions. The drugs in the list of essential medicines are suitable for basic medical and health needs, the dosage form is appropriate, reasonable, can be guaranteed, and the public can obtain drugs fairly, China has implemented the national essential drugs list since September 21, 2009, many people want to know and then inquire about it?

You can query the basic catalog of drugs in the State Food and Drug Administration, and you can also query in the database, which can not only query the basic catalog of drugs, but also query the data of drug research and development, market, etc., which is more comprehensive and conducive to analysis.

Query the list of basic drugs in the database

More than 70,000 items of data from the National Essential Medicines Catalogue have been accepted in the database. Integrate the 18th, 12th and 09th editions of the national basic drug catalogue, and summarize the basic drug varieties added by 9 provinces and cities since 13 years, standardize and unify the name, dosage form and specification, and you can easily and quickly query the basic drug situation of the drug entering the country and the provinces. Avoid the inconvenience caused by repeated inquiries from the provincial health and family planning commissions, and save query time.

List of basic drugs. The basic drug catalog information can be retrieved through three dimensions: drug name, basic drug serial number (2018 edition), and dosage form.

Execution status filter items support filtering in two fields: Executed and Deprecated.

The basic drug version filter item supports the filtering of three fields: the year version.

In addition to the search of a single option, you can also search for a combination of multiple options, and make full use of artificial intelligence technology to understand the information of the basic drug catalog from different dimensions and grasp the latest pharmaceutical trends.

Search method. The search results cover 8 dimensions of data information: drug name, dosage form, specification, region, document source, basic drug version, execution status, and serial number. The data sources are all from authoritative institutions and officials, and the data results are of great value and reference significance.

1. Basic drugs refer to drugs that can meet the basic medical and health needs, have appropriate dosage forms, ensure that the best can be equipped at the grassroots level, and can be fairly obtained by the people.

In 30% of the first-class urban community service institutions and county primary medical and health institutions, all provinces (autonomous regions and municipalities) implemented the basic drug system, including the implementation of provincial-level centralized, online public bidding and procurement, unified distribution, all equipped with the use of essential drugs and achieved zero-margin sales.

By 2020, we will fully implement a standardized national basic drug system covering both urban and rural areas. The establishment of a national basic drug system will play an important role in protecting the health of all people, standardizing the rational use of clinical drugs, promoting the reform of the medical insurance system, and correctly guiding drug research and development.

The NCMS Catalogue is a reimbursement catalogue of medical drugs for the New Rural Cooperative Medical System, which has no specific definition and is different from place to place. It is basically formulated according to the principle of clinical necessity, common use, and low price.

There are two kinds of basic drug catalogs, one is the national basic drug catalog, which can be found on the Internet, with a total of 520 kinds of drugs, also known as the 520 catalog.

The second is the local basic drug catalog, which is supplemented in the national basic drug catalog, and there are more than 1,000 kinds of drugs in Jiangxi.

The composition of the basic drug catalogue is mainly commonly used in clinical practice, and it is a basic drug. The most frequently used medicines.

The list of low-cost drugs is calculated according to the amount of daily consumption, and the daily use amount of Western medicine does not exceed 3 yuan, and the amount of traditional Chinese medicine does not exceed 5 yuan. It's not the same everywhere. Low-priced drugs are active catalogs and are subject to change at any time.

NCMS is only applicable to the reimbursement of NCMS. Therefore, the proportion of primary medical institutions is larger, and the reimbursement ratio is higher within the limit.

The current policy implemented by the basic drug catalogue is similar to that of Class A medical insurance, which means that the reimbursement ratio of basic drugs is the highest and the scope of application is not limited.

The list of low-cost drugs is only a threshold for hospital procurement, and the scope of application of Xidan is not limited. It is not directly related to reimbursement, but drugs purchased through low-cost drugs are generally included in the local medical insurance list.

The implementation of NCMS is now relatively rare. Basically, they are mainly basic drugs and low-cost drugs.

You can understand it this way, the NCMS catalogue is about equal to the basic drug basic equipment catalogue + low-cost drug grassroots equipment catalogue.

The three types you mentioned are all attributes of the drug's posture and body, and the scope of implementation is also different. The three catalogs may overlap, but the priority of implementation is basic drugs, low-cost drugs that won the bid, and NCMS.

The NCMS catalogue is about to be phased out, and there is no NCMS reimbursement catalogue in places where basic drug procurement and low-cost drug procurement are generally implemented.

Extended reading: [Insurance] How to buy, which one is better, teach you to avoid these insurance"pits"

In May 2013, the new basic drug catalogue triggered a channel readjustment.

In August 2009, the Ministry of Health promulgated the National List of Essential Drugs, and since then China has launched the essential drug system.

The 2009 edition of the basic drug catalogue is the first basic drug edition, including 307 drugs, which is only applicable to primary medical institutions, and has the meaning of detection in the market, that is, the "basic version".

In accordance with the relevant provisions of the National Essential Medicines List, the Essential Medicines List must be adjusted every three years.

Basic drugs refer to drugs that can meet the basic medical and health needs, appropriate dosage forms, ensure that the best can be equipped, and the people can obtain them fairly.